New and innovative approach for successful vaccination against Chlamydia infections Chlamydiae are the most common, sexually transmitted, bacterial pathogens in the world. Every year around 100 million people contract Chlamydia infections, which are one of the main causes of female infertility and ectopic pregnancies and can also lead to blindness – especially in developing countries.An international research team discovered how to stimulate the immune response to Chlamydiae both efficiently and preventively
New nanotechnology drug to control blindness A innovative product in the form of droplets, reduces the cost of current medications. It is a nanotechnology product, which works with last generation liposomes particles, concentrated in droplets, which function as a conveyor that wraps proteins or antibody fragments and allow its passage into the eye. Once inside, it releases the drugs.
New conductive ink for electronic apparel Researchers have developed a new ink that can be printed on textiles in a single step to form highly conductive and stretchable connections. This new functional ink will enable electronic apparel such as sportswear and underwear incorporating sensing devices for measuring a range of biological indicators such as heart rate and muscle contraction.
Investigation examines bitter dispute over e-cigarettes in the public health community An investigation reveals how the controversial concept of 'harm reduction', embraced enthusiastically by the tobacco industry, has sharply divided the public health community when it comes to the discussion around e-cigarettes.As smoking declines, more are likely to quit Smokeless tobacco and, more recently, e-cigarettes have been promoted as a harm reduction strategy for smokers who are “unable or unwilling to quit.” The strategy, embraced by both industry and some public health advocates, is based on the assumption that as smoking declines overall, only those who cannot quit will remain. A new study has found just the opposite.